Cipla to focus on open market drug sales to sustain profitab

Cipla to focus on open market drug sales to sustain profitability


During the period ended March, Cipla registered a net profit of Shs24.1b, returning to profitability from a loss making position in the 2020/21 financial year mainly due to improvement in gross...

Related Keywords

Malawi , , Cipla , Ministry Of Health , Cipla Quality Chemical , Ajay Kumar Pal , Emmanuel Katongole ,

© 2025 Vimarsana